Spectrum News: FDA proposes annual COVID boosters
UC expert says the proposal makes perfect sense
The FDA is recommending an annual COVID-19 booster shot for most adults and children. In doing so, the FDA hopes to simplify the vaccination process and avoid confusion over timing for scheduling boosters. Spectrum News interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to get his reaction to this recommendation.
"I think it makes perfect sense from a public health perspective," said Fichtenbaum. "You really need to be able to create something that makes sense for people, and annual vaccinations are things that people can get and what we really have to do is get to the point where people are protecting themselves from the most serious consequences of COVID infection."
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Colleen Kelley/UC Marketing + Brand
Fichtenbaum was asked about the speed with which the first COVID-19 vaccines were developed and if this FDA recommendation quiets some of the concerns about the safety and effectiveness of the vaccine.
"I think it's a recognition that we have done a lot of studies on the safety," Fichtenbaum said. "We have studied hundreds of thousands of people worldwide using a multitude of different vaccines and we really understood more than any other vaccine under a microscope how we can define any of the adverse effects. I think we know a lot about this vaccine, and I think we can reassure the public that is generally safe and does what we want it to do, which is it prevents people from getting seriously ill and suffering the worse complications that we've seen from COVID."
Fichtenbaum was asked about the current guidance related to the COVID-19 vaccines.
"Right now, we're still under a situation where people get an initial vaccine, and then we often recommend a boost of the immunity, but we did this so rapidly under the gun of a pandemic where people were dying, as people may forget back in 2020," Fichtenbaum said. "It's already been three years and people may forget how hospitals were full, ICUs were full and so we really did this very quickly. It may be that we get to the point where the kind of vaccines we administer in the next few years will provide a little long-lasting immunity and just one vaccine is all you will need to give your immune system a boost, and that's what our hope is."
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.